StockData
YDESNasdaqServices-Medical LaboratoriesFiscal year ends December 31Also trades as YDESW

YD Bio Ltd

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 30, 2026
$6.12+0.20 (+3.38%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

YD Bio Ltd revenue by segment

No segment breakdown reported

YD Bio does not break out revenue by segment, region or product in the tagged data of its filings for this period type.